Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple postoperative intravenous tranexamic acid dosing after total knee arthroplasty
ChiCTR1900022737Phase 4Completed
- Sponsor
- Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in osteoarthritis (OA) (3 arms), sponsored by Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Primary endpoints: Hematocrit and Hemoglobin. Started Apr 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1900022737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022737.